GEN Exclusives

More »

GEN News Highlights

Back to Item »

Amag Investor MSMB Makes $18 per Share Takeover Bid for Firm to Stop Merger with Allos

MSMB claims Amag’s proposed $686 million deal with Allos will benefit neither company nor shareholders.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Why Some People Are Anti-GMO?

Do you think GMOs would be viewed more favorably if more attention was paid to the resulting product rather than the GMO technology used to produce it?

More »